Press ReleaseCOUR Pharmaceuticals Appoints Paul M. Peloso, MD, as Chief Medical Officer Press Release / lsc-webmaster
Press ReleaseCOUR Pharmaceuticals Secures $105 Million in Series A Financing Co-Led by Lumira Ventures and Alpha Wave Ventures Press Release / lsc-webmaster
Press ReleaseCOUR Pharmaceuticals Appoints Dannielle Appelhans as Chief Operating Officer Press Release / lsc-webmaster
Press ReleaseCOUR Pharmaceuticals Announces Biotechnology Industry Veteran Robert F. Carey Joins Board of Directors as Lead Independent Director Press Release / lsc-webmaster
Press ReleaseCOUR Pharmaceuticals Announces FDA Clearance of Investigational New Drug Application for Myasthenia Gravis Press Release / lsc-webmaster
Press ReleaseCOUR Pharmaceuticals Announces $30M Financing Led by Alpha Wave Ventures Press Release / lsc-webmaster
Press ReleaseCOUR NanoParticle (CNP) Technology Induces Antigen Specific Tolerance, Halting the Progression of Type 1 Diabetes in Spontaneous NOD Model Press Release / lsc-webmaster
Press ReleaseCOUR Pharmaceuticals Appoints Brian C. Bock as Chief Financial Officer Press Release / lsc-webmaster
Press ReleaseCOUR Pharmaceuticals Receives FDA Fast Track Designation for CNP-104 for the Treatment of Primary Biliary Cholangitis Press Release / lsc-webmaster
